Finance

Beta
Lists
ILA:ASX
Island Pharmaceuticals Ltd
A$0.38
+2.70%
(+0.0100) 1D
Jun 4, 3:06:46 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for ILA...
Open
A$0.37
High
A$0.39
Low
A$0.37
Mkt. cap
110.93M
Avg. vol.
324.76K
Volume
247.22K
52-wk high
A$0.63
52-wk low
A$0.13
EPS
-A$0.03
Shares outstanding
295.92M
Open
A$0.37
High
A$0.39
Low
A$0.37
Mkt. cap
110.93M
Avg. vol.
324.76K
Volume
247.22K
52-wk high
A$0.63
52-wk low
A$0.13
EPS
-A$0.03
Shares outstanding
295.92M
News stories
From sources across the web
About Island Pharmaceuticals Ltd
CEO-
Employees-
Founded2017
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
11.03K
11.03K
20.39K
20.39K
Cost of goods sold
349.50K
349.50K
674.76K
674.76K
Cost of revenue
349.50K
349.50K
674.76K
674.76K
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
745.61K
745.61K
594.64K
594.64K
Operating expense
885.48K
885.48K
1.80M
1.80M
Total operating expenses
1.23M
1.23M
2.48M
2.48M
Operating income
-1.22M
-1.22M
-2.46M
-2.46M
Other non operating income
-
-
-
-
EBT including unusual items
-1.19M
-1.19M
-2.41M
-2.41M
EBT excluding unusual items
-1.19M
-1.19M
-2.41M
-2.41M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.19M
-1.19M
-2.41M
-2.41M
Net profit margin
-10,815.29%
-10,815.29%
-11,797.12%
-11,797.12%
Earnings per share
-
-
-
-
Interest and investment income
29.24K
29.24K
54.50K
54.50K
Interest expense
-
-
-
-
Net interest expenses
29.24K
29.24K
54.50K
54.50K
Depreciation and amortization charges
-
-
26.32K
26.32K
EBITDA
-
-
-2.43M
-2.43M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more